Serum zinc

1. Zinc aspartate increases serum zinc in humans.

   “Zinc-deficient elderly participants received zinc aspartate supplementation for approximately 7 days, resulting in increased serum zinc levels, IFN-γ production”

   Human trialzinc-deficient elderly participantsapproximately 7 days

   Zinc Supplementation Partially Reconstitutes Impaired Interferon-γ Production in the Elderly

   International journal of molecular sciences·20 Jan 2026

More on Zinc aspartate

1. Serum zinc raises the risk of hypertensive crisis in humans (HR 1.09, 95% CI 1.01-1.18).

   “and hypertensive crisis (HR 1.09, 95% CI 1.01-1.18; P = .028).”

   Humanszinc deficiency (< 0.7 μg/mL)5 yearsn = 47,843

   Association between serum zinc levels and new-onset hypertension: A 5-year retrospective cohort study

   Medicine·1 Sep 2026

More on Hypertensive crisis

1. Serum zinc raises the risk of secondary hypertension in humans (HR 1.82, 95% CI 1.45-2.29).

   “secondary hypertension (HR 1.82, 95% CI 1.45-2.29; P < .001)”

   Humanszinc deficiency (< 0.7 μg/mL)5 yearsn = 47,843

   Association between serum zinc levels and new-onset hypertension: A 5-year retrospective cohort study

   Medicine·1 Sep 2026

More on Secondary hypertension

1. Serum zinc raises the risk of hypertension in humans (HR 1.20, 95% CI 1.14-1.25).

   “Zinc deficiency was significantly associated with primary hypertension (hazard ratio [HR] 1.20, 95% confidence interval [CI] 1.14-1.25; P < .001)”

   Humanszinc deficiency (< 0.7 μg/mL)5 yearsn = 47,843

   Association between serum zinc levels and new-onset hypertension: A 5-year retrospective cohort study

   Medicine·1 Sep 2026

More on Hypertension